Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled Trials

Houlin Hong, Jack Donlon, Martin Schaefer, Susanne Sarkar, Dragana Bugarski-Kirola, Mujeeb U. Shad, Wei Hou, Matthias Kirschner, Sajoy P. Varghese, Ludmil Mitrev, Valentina Echeverria, John Dibato, Selene R. T. Veerman, Rohit Aiyer, Thomas N. Ferraro, Gerardo Villarreal, Shafiqur Rahman, Trevor W. Stone, Maju M. Koola

Open source

DOI: 10.1007/s40261-025-01465-4
Published: 2025-08-01
Container: Clinical Drug Investigation
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40261-025-01465-4,
  title = {Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled Trials},
  author = {Houlin Hong and Jack Donlon and Martin Schaefer and Susanne Sarkar and Dragana Bugarski-Kirola and Mujeeb U. Shad and Wei Hou and Matthias Kirschner and Sajoy P. Varghese and Ludmil Mitrev and Valentina Echeverria and John Dibato and Selene R. T. Veerman and Rohit Aiyer and Thomas N. Ferraro and Gerardo Villarreal and Shafiqur Rahman and Trevor W. Stone and Maju M. Koola},
  year = {2025},
  journal = {Clinical Drug Investigation},
  doi = {10.1007/s40261-025-01465-4},
  url = {https://doi.org/10.1007/s40261-025-01465-4}
}

RIS

TY  - JOUR
TI  - Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled Trials
AU  - Houlin Hong
AU  - Jack Donlon
AU  - Martin Schaefer
AU  - Susanne Sarkar
AU  - Dragana Bugarski-Kirola
AU  - Mujeeb U. Shad
AU  - Wei Hou
AU  - Matthias Kirschner
AU  - Sajoy P. Varghese
AU  - Ludmil Mitrev
AU  - Valentina Echeverria
AU  - John Dibato
AU  - Selene R. T. Veerman
AU  - Rohit Aiyer
AU  - Thomas N. Ferraro
AU  - Gerardo Villarreal
AU  - Shafiqur Rahman
AU  - Trevor W. Stone
AU  - Maju M. Koola
PY  - 2025
JO  - Clinical Drug Investigation
DO  - 10.1007/s40261-025-01465-4
UR  - https://doi.org/10.1007/s40261-025-01465-4
ER  -

APA

Hong, H., Donlon, J., Schaefer, M., Sarkar, S., Bugarski-Kirola, D., Shad, M. U., Hou, W., Kirschner, M., Varghese, S. P., Mitrev, L., Echeverria, V., Dibato, J., Veerman, S. R. T., Aiyer, R., Ferraro, T. N., Villarreal, G., Rahman, S., Stone, T. W., & Koola, M. M. (2025). Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled Trials. Clinical Drug Investigation. https://doi.org/10.1007/s40261-025-01465-4

Source records

crossref · retrieved 2026-09-25T18:43:30.372Z